Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues
JRSM Cardiovascular Disease · 2015
DOI: 10.1177/2048004015576008 ↗Kurz gefasst
Fallbericht in der Zeitschrift JRSM Cardiovascular Disease, 2015. Verfasst von Umar Y Raja und 3 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Endocrinology Department, Warwick Hospital, Warwick, UK. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Glucagon like peptide (GLP-1) analogues are a relatively novel medication developed primarily for the treatment of type 2 diabetes since 2005. Although GLP-1 analogues have been shown to be more effective in the first few years of diagnosis in type 2 diabetes, we report a case of a patient with longstanding insulin-dependent diabetes started on a GLP-1 analogue, liraglutide, who now has controlled blood sugars without the need of insulin.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diabetes and Endocrinology Department, Warwick Hospital, Warwick, UK.
- Diabetes Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Zitieren
APA
Raja, U. Y., Eastaugh, A. E., Younas, M. S., & Hanif, W. (2015). Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues. JRSM Cardiovascular Disease. https://doi.org/10.1177/2048004015576008
Vancouver
Raja UY, Eastaugh AE, Younas MS, Hanif W. Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues. JRSM Cardiovascular Disease. 2015. doi:10.1177/2048004015576008
BibTeX
@article{Raja2015,
author = {Raja, Umar Y and Eastaugh, Alison E and Younas, Mohammed S and Hanif, Wasim},
title = {Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues},
journal = {JRSM Cardiovascular Disease},
year = {2015},
doi = {10.1177/2048004015576008}
}
EUVIMED